Canino, Fabio
 Distribuzione geografica
Continente #
EU - Europa 290
NA - Nord America 267
AS - Asia 62
SA - Sud America 1
Totale 620
Nazione #
US - Stati Uniti d'America 262
IT - Italia 111
IE - Irlanda 55
GB - Regno Unito 48
HK - Hong Kong 28
SE - Svezia 25
DE - Germania 24
CN - Cina 23
FI - Finlandia 9
FR - Francia 6
TR - Turchia 4
BG - Bulgaria 3
CR - Costa Rica 3
CA - Canada 2
IL - Israele 2
PL - Polonia 2
TW - Taiwan 2
AL - Albania 1
BE - Belgio 1
BR - Brasile 1
DK - Danimarca 1
ES - Italia 1
IN - India 1
JP - Giappone 1
NL - Olanda 1
NO - Norvegia 1
RU - Federazione Russa 1
VN - Vietnam 1
Totale 620
Città #
Dublin 55
Chandler 51
Ashburn 50
Bologna 32
Enfield 32
Hong Kong 28
Nyköping 25
Fairfield 24
New York 23
San Diego 10
Seattle 9
Caprarola 8
Helsinki 8
Houston 7
Milan 7
Phoenix 7
Shanghai 7
Cardiff 6
Beijing 5
Bremen 5
London 5
Reggio Emilia 5
Sassuolo 5
Savona 5
Frankfurt am Main 4
Guangzhou 4
Lüleburgaz 4
Princeton 4
Wilmington 4
Woodbridge 4
Ann Arbor 3
Los Angeles 3
Parma 3
San José 3
Sofia 3
Acton 2
Arcola 2
Brooklyn 2
Cambridge 2
Casalgrande 2
Florence 2
Frattamaggiore 2
Modena 2
Naples 2
Noicattaro 2
Norwalk 2
Palermo 2
Rimini 2
Sant'Egidio alla Vibrata 2
Taipei 2
Toronto 2
Atlanta 1
Bagnacavallo 1
Bengaluru 1
Brussels 1
Edinburgh 1
Falkenstein 1
Fiorenzuola D'arda 1
Groningen 1
Hangzhou 1
Hanoi 1
Jerusalem 1
Lappeenranta 1
Madrid 1
Manhattan 1
Manoppello 1
Nagold 1
New Orleans 1
Oslo 1
Paris 1
Pisa 1
Rome 1
Salsomaggiore Terme 1
Sant'agata Sul Santerno 1
St Louis 1
Tel Aviv 1
Tirana 1
Vinhedo 1
Totale 517
Nome #
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center 101
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 101
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 97
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges 82
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis. 59
Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical cases 43
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 42
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. 39
Adding weekly carboplatin to sequential anthracycline and paclitaxel-based chemotherapy as neoadjuvant treatment for triple negative breast cancer (TNBC) patients: a propensity scorematched study 36
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation (British Journal of Cancer, (2023), 128, 2, (266-274), 10.1038/s41416-022-02050-8) 15
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation 10
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 7
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis 2
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 1
Totale 635
Categoria #
all - tutte 4.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.691


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022118 0 34 2 1 11 1 6 15 9 2 19 18
2022/2023286 15 25 10 17 20 18 6 12 68 2 83 10
2023/2024231 22 14 27 31 22 31 41 20 16 7 0 0
Totale 635